Increased serum cathepsin K in patients with coronary artery disease. - Test2 - elhamkhani - TriplyDB

Increased serum cathepsin K in patients with coronary artery disease.

Increased serum cathepsin K in patients with coronary artery disease.

http://www.wikidata.org/entity/Q33822554

about

Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.Lack of Superiority for Soluble ST2 over High Sensitive C-Reactive Protein in Predicting High Risk Coronary Artery Calcium Score in a Community Cohort Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability.Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice.

P2860

Q36139664-D8D03D1A-4DDC-46BA-8CCE-6AC02A373C91 Q37231845-9137BD98-245C-4C79-80FD-95236561A738 Q42376295-C9A48C24-35F2-4307-B1C8-D2C6325FA365 Q47616758-C89EC4FE-E070-4512-AAF1-F7B6207C7E65

P2860

Increased serum cathepsin K in patients with coronary artery disease.

http://www.wikidata.org/entity/Q33822554

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Increased serum cathepsin K in patients with coronary artery disease.

@ast

Increased serum cathepsin K in patients with coronary artery disease.

@en

type

label

Increased serum cathepsin K in patients with coronary artery disease.

@ast

Increased serum cathepsin K in patients with coronary artery disease.

@en

prefLabel

Increased serum cathepsin K in patients with coronary artery disease.

@ast

Increased serum cathepsin K in patients with coronary artery disease.

@en

P1433

Q33822554-E11B0611-4A07-45F0-9A6F-2A53703B2F80

P1476

Q33822554-05EFBD4F-5D7E-4F5D-9054-562CF5E7BB60

P2093

Q33822554-05C92233-CE9A-4AAE-8B76-B12B225C7C90

Q33822554-311B59E4-500A-41EA-8853-AFD75AA8F5B0

Q33822554-32E34749-B4B3-48BB-8A96-C24EA3632CFC

Q33822554-67EF27FE-D69E-4666-A907-73F786D2946B

Q33822554-7C52987D-57C3-4E47-A13E-2CC2F76DB8C3

Q33822554-B070524C-F194-4BC2-8AF7-3AB09C81C616

Q33822554-B34789E5-F2B3-4911-9E0F-5D5B044B482B

Q33822554-CC084E16-6CF1-495D-B6BD-4DF7C831C0D6

Q33822554-D243A5EC-5F4E-4D42-8E70-DAB4DCA91979

Q33822554-E64A8385-01A0-49BE-8A70-BD559868A4AC

P2860

Q33822554-0C209086-816F-4DA0-A954-6B38C15F18E2

Q33822554-0E0CE5BA-708D-457B-B1E8-6274F8C6C439

Q33822554-112DDE22-9FD7-4069-B332-47FF9074C682

Q33822554-15C0C8F6-850B-4953-93EF-3B2F70F2FE3C

Q33822554-18F2A459-4533-4A92-99B5-09722B82F0D6

Q33822554-27D2AFA3-DD28-41C6-9F53-AACF78953B2F

Q33822554-2BD8455C-64A7-41D0-A418-D18C98A15E4D

Q33822554-2CF6A08E-67C2-4ACC-A7B2-B61512BD4B6A

Q33822554-32CD5447-8DC5-465B-9C90-B1DF016958E9

Q33822554-4237ADC9-4898-424D-AD00-DD8811B448AB

P304

Q33822554-B3CE0748-27D3-4FD9-BB64-5CA2A72F067E

P31

Q33822554-6950F0D5-516F-46C9-AC9D-663DF7A96532

P356

Q33822554-699F30A7-959C-404E-99CF-C798FD8E2205

P433

Q33822554-C06CF2C6-8540-4671-BCDC-485861EA8DB0

P478

Q33822554-7C7818FF-0D53-4EEB-BC73-8B8CBE6BF9B0

P577

Q33822554-6C33342A-F291-4710-8FAB-F1ABBF849B58

P5875

Q33822554-EF7E3A80-6572-4FAC-91C0-201046B1904C

P698

Q33822554-D5FC5722-64DD-4823-91C1-20D111E0DDCF

P932

Q33822554-85B22B33-5278-43EE-B003-9EA98A54738F

P356

YMJ.2014.55.4.912

P1433

Yonsei Medical Journal

P1476

Increased serum cathepsin K in patients with coronary artery disease.

@en

P2093

Dehao Jin

http://www.w3.org/2001/XMLSchema#string

Enbo Zhu

http://www.w3.org/2001/XMLSchema#string

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Guangxian Zhao

http://www.w3.org/2001/XMLSchema#string

Haiying Jiang

http://www.w3.org/2001/XMLSchema#string

Jiyong Jin

http://www.w3.org/2001/XMLSchema#string

Lan Cui

http://www.w3.org/2001/XMLSchema#string

Xiang Li

http://www.w3.org/2001/XMLSchema#string

Xiangshan Li

http://www.w3.org/2001/XMLSchema#string

Xianwu Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Cystatin C deficiency in human atherosclerosis and aortic aneurysms

Lysosomal cysteine proteases: facts and opportunities.

Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication

Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3

Inflammation and atherosclerosis

C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consen

Third universal definition of myocardial infarction.

Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro.

Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.

P304

912-919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2014.55.4.912

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263323492

http://www.w3.org/2001/XMLSchema#string

P698

24954318

http://www.w3.org/2001/XMLSchema#string

P932

4075394

http://www.w3.org/2001/XMLSchema#string